FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2010-11-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2010.09.129PMID 20933505PMCID PMC2981438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer

  2009cited by this paper
• Expression and localization of FOXO1 in non-small cell lung cancer.

  2009cited by this paper
• The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors*

  2009cited by this paper
• EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells

  2008cited by this paper
• Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells

  2008cited by this paper
• FOXO-binding partners: it takes two to tango

  2008cited by this paper
• E2F-1 regulates expression of FOXO1 and FOXO3a.

  2007cited by this paper
• FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

  2007cited by this paper
• FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A.

  2007cited by this paper
• FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.

  2006cited by this paper
• A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression

  2006cited by this paper
• The Oncogenic TLS-ERG Fusion Protein Exerts Different Effects in Hematopoietic Cells and Fibroblasts

  2005cited by this paper
• EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.

  2005cited by this paper
• EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3

  2004cited by this paper
• Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein

  2004cited by this paper
• Targeting of EWS/FLI‐1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro

  2004cited by this paper
• COL11A2 Collagen Gene Transcription Is Differentially Regulated by EWS/ERG Sarcoma Fusion Protein and Wild-type ERG*

  2003cited by this paper
• Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells

  2003cited by this paper
• Identification of p21 WAF1/CIP1 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein*

  2003cited by this paper
• EWS/FLI function varies in different cellular backgrounds.

  2003cited by this paper
• Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D

  2002cited by this paper
• Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression

  2001cited by this paper
• EWS·Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA Splicing*

  2000cited by this paper
• Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein

  1999cited by this paper
• Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein

  1999cited by this paper
• EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic

  1997cited by this paper
• DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma

  1994cited by this paper
• Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

  1992cited by this paper
• Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors

  1992cited by this paper

• PRC2/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma.

  2025cites this paper
• Targeting friend leukemia integration 1: A promising approach for prevention and treatment of solid tumors.

  2025cites this paper
• Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets.

  2025cites this paper
• Signaling pathways and targeted therapies in Ewing sarcoma.

  2024cites this paper
• Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas

  2024cites this paper
• Ewing sarcoma from molecular biology to the clinic

  2023cites this paper
• Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives

  2022cites this paper
• The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review

  2022influential citation
• Association of FOXO1 Rs17592236 Polymorphism and Tumor Size in Papillary Thyroid Carcinoma.

  2022cites this paper
• Epigenetic and Transcriptional Signaling in Ewing Sarcoma—Disease Etiology and Therapeutic Opportunities

  2022influential citation
• A Novel Defined Hypoxia-Related Gene Signature for Prognostic Prediction of Patients With Ewing Sarcoma

  2022cites this paper
• The Role of Forkhead Box Family in Bone Metabolism and Diseases

  2022cites this paper
• Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives

  2021cites this paper
• Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation

  2021cites this paper
• Intrinsically Disordered Proteins as Regulators of Transient Biological Processes and as Untapped Drug Targets

  2021cites this paper
• Role of immunotherapy in Ewing sarcoma

  2020cites this paper
• Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter

  2020cites this paper
• Precision medicine in Ewing sarcoma: a translational point of view

  2020cites this paper
• An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning

  2020cites this paper
• Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma

  2020cites this paper
• Autophagy and Redox Homeostasis in Parkinson's: A Crucial Balancing Act

  2020cites this paper
• BET bromodomains' functions in bone-related pathologies.

  2019cites this paper
• Identification of key genes and pathways in Ewing’s sarcoma patients associated with metastasis and poor prognosis

  2019cites this paper
• Role of FoxO Proteins in Cellular Response to Antitumor Agents

  2019cites this paper
• Identi fi cation of key genes and pathways in Ewing ’ s sarcoma patients associated with metastasis and poor prognosis

  2019cites this paper
• Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma

  2019influential citation
• Omic approaches to pediatric bone sarcomas

  2019cites this paper
• A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins

  2017cites this paper
• Potential approaches to the treatment of Ewing's sarcoma

  2016cites this paper
• Ewing sarcoma: a chronicle of molecular pathogenesis.

  2016cites this paper
• EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma

  2015cites this paper
• Molecular Genetics of Ewing Sarcoma

  2015cites this paper
• Structure-Function Based Molecular Relationships in Ewing's Sarcoma

  2015cites this paper
• Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy

  2014cites this paper
• Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis

  2013cites this paper
• Functional Interactions in Transcription and Splicing of Ewing’s Sarcoma

  2013cites this paper
• Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma

  2013cites this paper
• Cancer genetics and genomics of human FOX family genes.

  2013cites this paper
• Liver X Receptor α Inhibits Osteosarcoma Cell Proliferation through Up-Regulation of FoxO1

  2013cites this paper
• The effect of EWS and its oncogenic derivative EWS-FLl1 on transcriptional and post-transcriptional gene regulation in Ewing sarcoma

  2012cites this paper
• Mechanisms of transcriptional repression by EWS-FLI1 in Ewing Sarcoma

  2012cites this paper
• The Molecular Basis of Sarcoma

  2011cites this paper
• A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs

  2011cites this paper
• Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family

  2010cites this paper